Publications
145
Citations
1,402
Est. group size
~9
Recurring co-author estimate
Active years
28
Publishing since 1999
Aline Paixão Becker's research focuses on brain tumors, especially gliomas and glioblastoma, examining how molecular features (such as gene mutations, microRNAs, and specific proteins) relate to patient outcomes, treatment resistance, and survival. Her work combines laboratory studies of tumor biology with clinical and radiological data from large multi-institutional trials to help distinguish true tumor progression from treatment-related changes and to identify markers that predict how patients respond to radiation and chemotherapy.
Publication output was moderate and fairly steady from 2017-2020, dipped in 2021-2022, spiked sharply in 2023, and has since declined toward more typical levels, suggesting a period of concentrated collaborative output rather than a smooth long-term trend.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Functional outcome after repeat surgery of tumor progression or treatment-associated changes in high-grade glioma: Clinical and radiological predictors
Neuro-Oncology Practice · 2026
- P17.29.A CLINICORADIOLOGICAL DIFFERENTIATION BETWEEN PROGRESSIVE DISEASE AND TREATMENT-ASSOCIATED CHANGES IN 170 POST-RADIOTHERAPY RECURRENT DIFFUSE GLIOMAS
Neuro-Oncology · 2025
- Clinical Endpoints Correlation with Molecular Features in the NRG Oncology/RTOG 9802 Low-Grade Glioma, Low-Risk Observation Arm
International Journal of Radiation Oncology*Biology*Physics · 2024
- NCOG-19. FUNCTIONAL OUTCOME AFTER RE-RESECTION OF TUMOR PROGRESSION, MIXED LESION OR TREATMENT-ASSOCIATED EFFECTS IN IRRADIATED DIFFUSE GLIOMAS (GRADE 2-4): IDENTIFYING CLINICAL AND RADIOLOGICAL DETERMINANTS
Neuro-Oncology · 2024
- Hypoxia-Inducible Transgelin-2 Confers Treatment Resistance through Activation of PI3K/Akt/GSK3β Pathway in Glioblastoma
International Journal of Radiation Oncology*Biology*Physics · 2023
- PO-2218 RNAi-mediated silencing of PSMA7 sensitizes GBM cells to ionizing radiation and temozolomide
Radiotherapy and Oncology · 2023
- PO-1145 Targeting Transgelin-2 by novel small molecule inhibitors to circumvent resistance in glioblastoma
Radiotherapy and Oncology · 2023
- NTRK2 gene fusions are uncommon in pilocytic astrocytoma
Molecular Biology Reports · 2022
- EGFL7 expression profile in IDH-wildtype glioblastomas is associated with poor patient outcome
Journal of Pathology and Translational Medicine · 2022
- The Carbonic Anhydrase Inhibitor E7070 Sensitizes Glioblastoma Cells to Radio- and Chemotherapy and Reduces Tumor Growth
Molecular Neurobiology · 2021
- The T‐box transcription factor brachyury behaves as a tumor suppressor in gliomas
The Journal of Pathology · 2020
- Evaluation of the prognostic potential of <scp><i>EGFL7</i></scp> in pilocytic astrocytomas
Neuropathology · 2020
- miR-219a-2-3p Functions As A Tumor Suppressor In IDH Wild-Type Gliomas By Inhibiting TBK1
International Journal of Radiation Oncology*Biology*Physics · 2020
- Long-term analysis of the WHO-defined molecular subgroups of high-risk grade II gliomas treated with radiation and temozolomide on NRG Oncology/RTOG 0424.
Journal of Clinical Oncology · 2020
- Comprehensive Prognostic and Predictive Molecular Subgroup Analysis within the High-risk Treatment Arms of NRG Oncology/RTOG 9802: a Phase III Trial of RT versus RT + PCV in High-risk Low-grade Gliomas
International Journal of Radiation Oncology*Biology*Physics · 2019
- Neuro-Oncology×25
- International Journal of Radiation Oncology*Biology*Physics×18
- Journal of Clinical Oncology×6
- Radiotherapy and Oncology×5
- JAMA Oncology×2
- Monica Venere
Medicine · The Ohio State University
- Arnab Chakravarti
Medicine · The Ohio State University
- Pedro C. Silberman
Medicine · The Ohio State University
- Sara Khan
Medicine · The Ohio State University
- J. McElroy
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile